BONESUPPORT Calls 2026 AGM, Proposes No Dividend and New Incentive Plan

An announcement from BONESUPPORT HOLDING AB ( (SE:BONEX) ) is now available.

BONESUPPORT HOLDING AB has convened its Annual General Meeting for 12 May 2026 in Lund, setting out participation rules for shareholders, including registration deadlines, proxy procedures, and requirements for nominee-registered holdings. The agenda spans standard governance items such as board and auditor elections, remuneration guidelines, capital authorization, and a new long-term incentive program for senior executives and key employees.

The nomination committee proposes attorney Madeleine Rydberger as chair of the meeting and recommends decisions on board size, fees, and auditor appointments to be taken at the AGM. The board also proposes that no dividend be paid for the year, with SEK 1,202,961,052 in available funds carried forward, signaling a continued focus on reinvestment and capital flexibility through potential new share issues, share buybacks, and performance-based share programs.

The most recent analyst rating on (SE:BONEX) stock is a Buy with a SEK240.00 price target. To see the full list of analyst forecasts on BONESUPPORT HOLDING AB stock, see the SE:BONEX Stock Forecast page.

More about BONESUPPORT HOLDING AB

BONESUPPORT HOLDING AB is a Swedish medical technology company focused on orthobiologics, developing and commercializing injectable bone graft substitutes for treating bone infections, fractures, and other skeletal conditions. The company targets orthopedic surgeons and related specialists, primarily in Europe and the U.S., aiming to improve outcomes in complex bone disease and trauma cases.

Average Trading Volume: 343,997

Technical Sentiment Signal: Buy

Current Market Cap: SEK14.16B

For detailed information about BONEX stock, go to TipRanks’ Stock Analysis page.